NOD2 therapy (Traverse Biotech)

N/A

Report date: 2024/10/23 11:23:49

Base Information

Drug NameNOD2 therapy (Traverse Biotech)
Drug Alias NameN/A
ClassificationOther
Mechanisms of ActionNucleotide-binding oligomerization domain-containing protein 2 modulators
TargetsNucleotide-binding oligomerization domain-containing protein 2
Therapy Area/IndicationsOsteosarcomaNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTraverse Biotech Inc
China Registration ClassN/A

Develop Information

Active CompaniesTraverse Biotech Inc
Inactive CompaniesN/A
Active IndicationsOsteosarcoma
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A